National Health Investors, Inc. (NYSE:NHI - Free Report) - Investment analysts at Wedbush lowered their FY2024 EPS estimates for shares of National Health Investors in a research note issued on Wednesday, November 6th. Wedbush analyst R. Anderson now anticipates that the real estate investment trust will post earnings per share of $4.40 for the year, down from their previous forecast of $4.52. The consensus estimate for National Health Investors' current full-year earnings is $4.42 per share. Wedbush also issued estimates for National Health Investors' Q4 2024 earnings at $1.10 EPS, Q1 2025 earnings at $1.11 EPS, Q2 2025 earnings at $1.15 EPS, Q3 2025 earnings at $1.16 EPS and Q4 2025 earnings at $1.17 EPS.
NHI has been the topic of several other reports. Wells Fargo & Company cut shares of National Health Investors from an "overweight" rating to an "equal weight" rating and boosted their price target for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Truist Financial increased their price target on National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a report on Friday, August 30th. Finally, Bank of America began coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective on the stock. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, National Health Investors has an average rating of "Moderate Buy" and a consensus price target of $73.29.
Check Out Our Latest Report on NHI
National Health Investors Stock Performance
NYSE:NHI traded down $0.11 during midday trading on Monday, reaching $81.09. 175,473 shares of the company traded hands, compared to its average volume of 196,152. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.27. The company has a fifty day moving average price of $80.36 and a 200 day moving average price of $73.49. The firm has a market capitalization of $3.68 billion, a price-to-earnings ratio of 27.90, a price-to-earnings-growth ratio of 5.46 and a beta of 1.05. National Health Investors has a twelve month low of $50.57 and a twelve month high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the previous year, the firm earned $1.08 EPS. The firm's revenue for the quarter was up 1.7% on a year-over-year basis.
Institutional Trading of National Health Investors
Several large investors have recently made changes to their positions in NHI. Jupiter Asset Management Ltd. grew its holdings in National Health Investors by 448.7% in the first quarter. Jupiter Asset Management Ltd. now owns 76,875 shares of the real estate investment trust's stock worth $4,830,000 after purchasing an additional 62,865 shares during the period. Susquehanna Fundamental Investments LLC bought a new stake in National Health Investors in the 1st quarter valued at about $547,000. Strategic Financial Concepts LLC purchased a new position in National Health Investors in the 2nd quarter valued at approximately $28,000. Russell Investments Group Ltd. lifted its holdings in shares of National Health Investors by 733.8% in the first quarter. Russell Investments Group Ltd. now owns 53,783 shares of the real estate investment trust's stock worth $3,379,000 after buying an additional 47,333 shares in the last quarter. Finally, Acadian Asset Management LLC purchased a new position in National Health Investors during the second quarter worth about $457,000. Institutional investors and hedge funds own 62.51% of the company's stock.
National Health Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.44%. National Health Investors's dividend payout ratio is presently 123.71%.
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
